ANTIGEN LB39-AA
ANTIGEN LB39-AA Uses, Dosage, Side Effects, Food Interaction and all others data.
ANTIGEN LB39-AA is under investigation in clinical trial NCT01748747 (Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery).
| Trade Name | ANTIGEN LB39-AA |
| Generic | Melanoma antigen recognized by T-cells 1 |
| Melanoma antigen recognized by T-cells 1 Other Names | ANTIGEN LB39-AA, ANTIGEN SK29-AA, MART1 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here ANTIGEN LB39-AA
